XML 38 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Revenues $ 461 $ 767 $ 1,187 $ 1,136
Cost of revenues 6 237 28 475
Gross profit 455 530 1,159 661
Sales and marketing expenses 215 305 420 621
General and administrative expenses 913 827 1,913 1,621
Research and development costs 259 429 593 830
Operating Loss (932) (1,031) (1,767) (2,411)
Loss on extinguishment of debt (27,479) 0 (27,479) 0
Gain/(Loss) from change in fair value of hybrid financial instruments 36,773 (15,899) 5,603 (13,428)
Gain/(Loss)from change in fair value of derivative liability - warrants 42,409 (87) 921 1,695
Gain/(Loss) from change in fair value of derivative liability - Series C and D preferred stock and debentures 75,351 (37,941) (14,298) (31,270)
Interest expense related to convertible debt (2,003) (904) (4,395) (1,657)
Net Income (loss) 124,119 (55,862) (41,415) (47,071)
Dividends on convertible preferred stock 0 0 0 0
Net Income (loss) available to common shareholders 124,119 (55,862) (41,415) (47,071)
Comprehensive income (loss):        
Net income (loss) 124,119 (55,862) (41,415) (47,071)
Other comprehensive loss - foreign currency translation adjustment (8) (4) (15) (13)
Comprehensive Income (loss) $ 124,111 $ (55,866) $ (41,430) $ (47,084)
Net income (loss) per share, basic and diluted:        
Basic earnings per share $ 0.11 $ (0.41) $ (0.13) $ (1.02)
Fully diluted (in dollars per share) $ 0.00 $ (0.41) $ (0.13) $ (1.02)
Weighted average number of common shares:        
Basic (in shares) 1,148,526,738 137,692,460 326,414,797 46,114,822
Fully diluted (in shares) 8,113,106,249 137,692,460 326,414,797 46,114,822